Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 8/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.39 |
| ▸ | MVD | P53602 | 1/20 | 0.32 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.30 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.30 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.30 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4309091 | 1.00 | LPAR3 (0.39) | LPAR3LPAR2LPAR1MVDSMPD1 | |
| SCHEMBL3228438 | 0.85 | MVD (0.35) | MVDFDPS | |
| Bromohydrin Pyrophosphate SCHEMBL2037203 | 0.85 | MVD (0.48) | MVD | |
| Bromohydrin Pyrophosphate SCHEMBL2968174 | 0.85 | MVD (0.48) | MVD | |
| Bromohydrin Pyrophosphate SCHEMBL4309089 | 0.85 | MVD (0.48) | MVD | |
| SCHEMBL3228433 | 0.85 | MVD (0.40) | MVD | |
| SCHEMBL3003035 | 0.83 | MVD (0.39) | MVD | |
| Bromohydrin Triphosphate SCHEMBL2034171 | 0.83 | MVD (0.46) | MVD | |
| SCHEMBL4309087 | 0.82 | CYP3A4 (0.30) | — | |
| SCHEMBL3215427 | 0.81 | MVD (0.38) | MVD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |